: Friday, July 10, 2020
Korea‘s Bio Industry
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
More than five months ha...
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
The most shocking news i...
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
“Please insert ‘severe’ ...
Pfizer Korea ignores reporters’ questions
“I do not think the ques...
Stigmatizing mental illness leads to high suicide rate
Thirty-six Koreans commi...
Korea needs English medical media outlet
Korean pharmaceutical an...
Why doesn’t Korea advertise condoms?
Korea takes up the lion’...
Korean food not as healthy as you think
With the Hallyu wave and...
Adolescent Protection Policy
E-mail address privacy
The Korean Doctors’ Weekly Co., Ltd.
76-1, Dongmak-ro, Mapo-gu, Seoul, Korea
Email : firstname.lastname@example.org
Title : Korea Biomedical Review
Online newspaper registration number : Seoul 아 04285
Date of registration : December 19, 2016
Publishing date : February 22, 2017
Publisher-Editor : Yang Kyung-cheol
Chief Executive Officer : Yang Kyung-cheol
Executive Editor : Choi Sung-jin
pyright © 2020 KBR. All rights reserved.
Back to Top